238
Views
51
CrossRef citations to date
0
Altmetric
Research Article

Neuroprotective activity of L-theanine on 3-nitropropionic acid-induced neurotoxicity in rat striatum

, , , &
Pages 673-684 | Received 29 Oct 2013, Accepted 03 Dec 2013, Published online: 23 Jan 2014

References

  • Cowan CM, Raymond LA. Selective neuronal degeneration in Huntington's disease. Curr Top DevBiol 2006;75:25–71.
  • Beal MF, Brouillet E, Jenkins BG, Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993;13:4181–92.
  • Alexi T, Hughes PE, Faull RLM, 3-Nitropropionic acid's lethal triplet: cooperative pathways of neurodegeneration. Neuroreport 1998;9(11):R57–64.
  • Fontaine MA, Geddes JW, Banks A, Butterfield DA. Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease. J Neurochem 2000;75(4):1709–15.
  • Binienda Z, Simmons C, Hussain S, Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain. Neurosci Lett 1998;251:173–6.
  • Tunez I, Montilla P, Del Carmen Munoz M, Protective effect of nicotine on 3-nitropropionic acid—induced oxidative stress in synaptosomes in an animal model of Huntington's diseases. Euro J Pharmacol 2004;504:169–75.
  • Terashima T, Takido J, Yokogoshi H. Time-dependent changes of amino acids in the serum, liver, brain and urine of rats administered with theanine. Biosci Biotechnol Biochem 1999;63:615–8.
  • Haskell CF, Kennedy DO, Milne AL, The effects of l-theanine, caffeine and their combination on cognition and mood. Biol Psychol 2008;77(2):113–22.
  • Kelly SP, Gomez-Ramirez M, Montesi JL l-Theanine and caffeine in combination affect human cognition as evidenced by oscillatory alpha-band activity and attention task performance. J Nutr 2008;138:1572S–77S.
  • Egashira N, Hayakawa K, Mishima K, Neuroprotective effect of gamma-glutamylethylamide (theanine) on cerebral infarction in mice. Neurosci Lett 2004;363:58–61.
  • Cho HS, Kim S, Lee SY, Protective effect of the green tea component, l-theanineon environmental toxins-induced neuronal cell death. Neurotoxicology 2008;29:656–62.
  • Kumar P, Kalonia H, Kumar A. Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats. J Asian Nat Prod Res 2009;11(5):439–50.
  • Kumar P, Kumar A. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism. Food Chem Toxicol 2009;47(10): 2522–30.
  • Kumar P, Kumar A. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food 2009;12:591–600.
  • Yokogoshi H, Kobayashi M, Mochizuki M, Effect of theanine, c-glutamylethylamide, on brain monoamines and striatal dopamine release in coscious rats. Neurochem Res 1998;23:667–73.
  • Mason R. 200 mg of Zen. l-Theanine boosts alpha waves, promotes alert relaxation. Altern Complement Ther 2001;7(3):91–5.
  • Kakuda T, Yanase H, Utsunomiya K, Protective effect of gamma-glutamylethylamide (theanine) on ischmic delayed neuronal death in gerbils. Neurosci Lett 2000;289:189–92.
  • Kakuda T. Neuroprotective effects of the green tea components theanine and catechins. Biol Pharm Bull 2002;25(12): 1513–8.
  • Frautschy SA, Hu W, Kim P, Phenolic anti-inflammatory antioxidant reversal of Ab-induced cognitive deficits and neuropathology. Neurobiol Aging 2001;22:993–1005.
  • Kumar P, Kumar A. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 2009;33(1):100–8.
  • Nowak G, Szewczyk B, Wieronska JM, Antidepressant like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats. Brain Res Bull 2003;61:159–64.
  • Porsolt RD, Anton G, Blavet N, Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379–91.
  • Lowry OH, Rosebrough NJ, Farr AL, Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–75.
  • H. Ohkawa, N. Ohishi, K. Yagi. Assay for lipid peroxides in animal tissues by thiobarbituric acid reactions. Anal Biochem 1979;95:351–8.
  • Moron M, Depierre JW, Mannervik BT. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochim Biophys Acta 1979;582: 67–78.
  • Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469–74.
  • Sinha AK. Colorimetric assay of catalase. Anal Biochemc 1972;47:389–94.
  • Slater EC, Bonner WD. The effect of fluoride on the succinic oxidase. System Biochem J 1952;52(2):185–196.
  • Mandavilli BS, Boldogh I, Van Houten B. 3-Nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by BcL- 2 overexpression in PC12 cells. Brain Res Mol Brain Res 2005;133(2):215–23.
  • Saydoff JA, Liu LS, Garcia RA, Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Brain Res 2003;994(1):44–54.
  • Pubill D, Verdaguer E, Canudas AM, Orphenadrine prevents 3-nitropropionic acid-induced neurotoxicity in vitro and in vivo. Br J Pharmacol 2001;132(3):693–702.
  • Nam E, Lee SM, Koh SE, Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum. Brain Res 2005;1046(1–2):90–6.
  • Palfi S, Ferrante RJ, Brouillet E, Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J. Neurosci 1996;16(9):3019–25.
  • Koutouzis TK, Borlongan CV, Scorcia TA, Systemic 3-nitrpropionic acid: long term effects on locomotor behavior. Brain Res 1994;646:242–6.
  • Hong JT, Ryu SR, Kim HJ, Neuroprotective effect of green tea extract in experimental ischemia—reperfusion brain injury. Brain Res Bull 2000 53:743–9.
  • Hong JT, Ryu SR, Kim HJ, Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res 2001 888:11–8.
  • Lee H, Bae JH, Lee SR. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J Neurosci Res 2004;77(6):892–900.
  • Mandel S, Weinreb O, Amit T, Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (−)-epigallocatechin-3-gallate: implications for neurodegenerative diseases. J Neurochem 2004;88(6):1555–69.
  • Egashira N, Hayakawa K, Osajima M, Involvement of GABA (A) receptors in the neuroprotective effect of theanine on focal cerebral ischemia in mice. J Pharmacol Sci 2007;105:211–4.
  • Nathan PJ, Lu K, Gray M, The neuropharmacology of l-theanine (N-ethyl-l-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother 2006;6(2):21–30.
  • Yamada T, Terashima T, Honma H, Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioral test. Biosci Biotechnol Biochem 2008;72:1356–9.
  • Egashira N, Ishigami N, PuF, Theanine prevents memory impairment induced by repeated cerebral ischemia in rats. Phytother Res 2008;22:65–8.
  • Haskell CF, Kennedy DO, Milne AL, The effects of l-theanine, caffeine and their combination on cognition and mood. Biol Psychol 2008;77(2):113–22.
  • Owen GN, Parnell H, De Bruin EA, The combined effects of l-theanine and caffeine on cognitive performance and mood. Nutr Neurosci 2008;11(4):193–8.
  • Wakabayashi C, Numakawa T, Ninomiya M, Behavioral and molecular evidence for psychotropic effects in l-Theanine. Psychopharmacology 2012;219(4):1099–109.
  • Kumar P, Kumar A. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food 2009 (c);12:591–600.
  • Browne SE, Ferrante RJ, Beal M F. Oxidative stress in Huntington's disease. Brain Pathol 1999;9(1):147–63.
  • Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA dependent superoxide production and neurotoxicity. Nature 1993;364(6437):535–7.
  • Kumar P, Kalonia H, Kumar A. Lycopene modulates nitric oxide pathways against 3-nitropropionic acid-induced neurotoxicity. Life Sci 2009;85(19–20):711–8.
  • Bhateja DK, Dhull DK, Gill A, Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms. Eur J Pharmacol 2012;674:33–43.
  • Tae Il Kim, Yong Kyung Lee, Sang Gi Park, L-theanine, an amino acid in green tea, attenuates β-amyloid-induced cognitive dysfunction and neurotoxicity: reduction in oxidative damage and inactivation of ERK/p38 kinase and NF-κB pathways. Free Radic Biol Med 2009;47:1601–10.
  • Kumar P, Padi SS, Naidu PS, Kumar A. Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 2006;17:485–92.
  • Cole CJ, Edmondson DE, Singer TP. Inactivation of succinate dehydrogenase by 3-nitropropionic acid. J Biol Chem 1979;254:5161–7.
  • Fu YT, He FS, Zhang SL, Zhang JS. Lipid peroxidation in rats intoxicated with 3-nitropropionic acid. Toxicology 1995;33(3):327–31.
  • Kappus H. Overview of enzyme systems involved in bioreduction of drugs and in redox cycling. Biochem Pharmacol 1986;35(1):1–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.